Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Utilisation and Safety Study of Mysimba in Europe and Contrave in the United States

NCT06089824 is registered in ClinicalTrials.gov with Currax Pharmaceuticals as lead sponsor.

NCT NCT06089824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06089824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Utilisation and Safety Study of Mysimba in Europe and Contrave in the United States
Lead sponsor
Currax Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
October 31, 2022
Enrollment
43,324 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity